Old Web
English
Sign In
Acemap
>
authorDetail
>
Tim Babinchak
Tim Babinchak
Medicine
Adverse effect
Intensive care medicine
Surgery
Pediatrics
4
Papers
109
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Clinical Outcomes of an Equine-Derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States
2019
Clinical Infectious Diseases
Jason S. Richardson
Geraldine S Parrera
Hugo Astacio
Harpreet Sahota
Deborah M. Anderson
Christine Hall
Tim Babinchak
Show All
Source
Cite
Save
Citations (10)
Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura
2017
Journal of Medical Economics
P. Donga
S. P. Bilir
Gregg Little
Tim Babinchak
Julie Munakata
Show All
Source
Cite
Save
Citations (6)
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
2008
Journal of Antimicrobial Chemotherapy
Krasimir Vasilev
Galina Reshedko
Remus Orăsan
Miguel Sánchez
Jüri Teras
Tim Babinchak
Gary Dukart
Angel Cooper
Nathalie Dartois
Hassan Gandjini
Russ Orrico
Evelyn J. Ellis-Grosse
Show All
Source
Cite
Save
Citations (93)
COLONIZATION OF ORTHOPAEDIC TRAUMA IMPLANTS IN PATIENTS WITHOUT EVIDENCE OF INFECTION
1998
Journal of Trauma-injury Infection and Critical Care
Brian Divelbiss
Maureen Murphy
Tim Babinchak
Spencer L. Butterfield
Barry L. Riemer
Show All
Source
Cite
Save
Citations (0)
1
map